Alopecia (hair-loss) remains a traumatic side-effect many cancer patients experience. A constant reminder of their disease, alopecia also alters patients’ facial features, thus leading them to reduced social interactions and even refusal of treatment.
The Paxman Scalp Cooling System, which effectively mitigates alopecia, is a product from Paxman Coolers Ltd (UK) with more than 1800 installations in Europe. The system consists of a mobile refrigeration unit connected to lightweight silicon caps. It has a special coolant circulating through the cap at – 4oC, which lowers scalp temperature to 8-10oC before, during, and following chemotherapy. Due to low scalp temperature blood flow to hair follicles is reduced, keeping hair-loss to the minimum.
How it works?
Scalp cooling works by lowering the temperature of the head and scalp immediately before, during, and after the administration of chemotherapy. This in turn reduces the blood flow to the hair follicles, thus preventing or minimising hair loss. Scalp cooling has found to be effective across a wide range of chemotherapy drugs such as Epirubicin, Doxorubicin, Taxol and Docetaxol.
Highlights: Effective across a wide range of drugs; double model available (with each patient treated independently); easy touch-screen display; five cap sizes for various head size shape and contour, effective insulation using Neoprene maintaining constant temperature, no cap changes during treatment; minimal nursing supervision; patient mobility.
Paxman-Orbis is now in India through:
Access Devices
Bangalore
Email: [email protected]
Website: www.accessdevices.in
- Advertisement -
